期刊文献+

变形配准与经验计算剂量累加法用于肺癌放疗计划累加剂量计算的研究 被引量:3

Application of deformable registration and empirical calculation method to calculate the accumulated dose for normal tissues and organs at risks in lung cancer radiotherapy plans
原文传递
导出
摘要 目的应用变形配准功能评价肺癌患者放疗计划中正常组织和危及器官的累加剂量,并与经验计算剂量累加法进行比较。方法回顾性分析10例肺癌患者,放疗前制定了三维适形或调强治疗计划,放疗过程中重新行CT模拟,并重新设计相同的治疗计划。采用Mimvista软件,运用变形配准,分别在2次CT图像上进行剂量累加。采用经验计算剂量累加法,计算2次放疗计划的正常组织和危及器官的累加剂量,分别对两种方法的双侧肺组织、心脏及脊髓的受照剂量体积以及平均剂量等参数,进行比较。结果定位和复位图像采用相同的计划方式时,两种方法所得正常组织和危及器官的累积受照体积和剂量等参数差异无统计学意义,仅右肺的平均剂量除外(t=2.98,P〈0.05)。结论变形配准法可以准确评价肺癌患者多次放疗计划中正常组织和危及器官的累加剂量。肺癌患者的靶区变化不大并且采用相同的计划方式时,应用经验计算剂量累加法,可粗略评价肺和心脏等正常组织和危及器官的剂量体积。 Objective To evaluate the accumulated doses to normal tissues and organs at risks (OARs) of patients with lung cancer in radiotherapy plans by using the deformable registration method, and make comparison with the empirical calculation method. Methods Ten patients with lung cancer were analyzed retrospectively. 3D-CRT or IMRT plans were designed before treatment. CT to simulator was rescanned and the same treatment plan was redesigned during radiotherapy. Based on the deformable registration method, the Mimvista software was used to calculate the accumulated doses to normal tissues and OARs in two CT images respectively. The empirical estimation algorithm was calculated by the linear relationship between the fractions and the total prescribed dose. Results The target coverage of patients had no significant difference in two plans. There were no significant differences in all the dose volume parameters for normal tissues and OARs, except the mean dose to right lung( t = 2.98 ,P 〈 0.05 ) when the the same plan was conducted in position-setting and reposition CT images. Conclusions The empirical estimation for the accumulated dose could be used to evaluate the dose and volume parameters for normal tissues and OARs in lung cancer by the same plan.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2012年第1期70-73,共4页 Chinese Journal of Radiological Medicine and Protection
基金 _山东省自然科学基金(ZR2010HM071)
关键词 变形配准 剂量累加 肺癌 Deformable registration Accumulated dose Lung cancer
  • 相关文献

参考文献11

  • 1余光伟,王连聪,朱小杨,卜路懿.非小细胞肺癌三维适形放疗期间肿瘤体积变化分析[J].中华放射医学与防护杂志,2010,30(4):445-447. 被引量:3
  • 2卢洁,李建彬,尹勇,陈进琥,刘翠翠,刘波,白曈,孙涛.两种方法评估肺癌患者三维适形放疗重复计划肺总体受照剂量体积效果比较[J].山东医药,2008,48(27):97-99. 被引量:5
  • 3王澜,李晓宁,吕冬婕,韩春,赵玉芹,高超.肺低剂量区体积预测急性放射性肺炎价值探讨[J].中华放射肿瘤学杂志,2010,19(4):296-300. 被引量:59
  • 4Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non- small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 1999,45 ( 2 ) :323 -329.
  • 5Piotrowski T, Mateeka-Nowak M, Mileeki P. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Neoplasma, 2005,52(1) :56-62.
  • 6Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys, 2001,51 (3) :650-659.
  • 7Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys, 1998,42 (1) :1-9.
  • 8Piper JW. Evaluation of an intensity-based free-form deformable registration algorithm. Med Phys, 2007,34(6) :2353-2354.
  • 9Choe J, Piper JW, Nelson AS, et al. Comparison of contour-to- CT registration techniques during adaptive re-planning of radiation therapy for patients with Bulky disease. IJROBP, 2007,69"(3 supplS) : S725.
  • 10Hugo GD, Campbell J, Zhang T, et al. Cumulative lung dose for several motion management strategies as a function of pre- treatment patient parameters. Int J Radiat Oncol Biol Phys, 2009,74(2) :593-601.

二级参考文献23

  • 1韩春,王澜,祝淑钗,迟子锋,曹彦坤.食管癌三维适形放疗中肺和食管损伤的相关因素分析[J].中华放射肿瘤学杂志,2007,16(2):103-107. 被引量:21
  • 2祝淑钗,沈文斌,李任,王玉祥,苏景伟,李娟.三维适形放疗食管癌所致放射性肺炎相关因素分析[J].中华放射医学与防护杂志,2007,27(2):161-164. 被引量:21
  • 3Graham MV,Purdy JA,Emami B,et al.Clinical dose-volume histogram ananlysis for pnumonitis after 3D treatment for non-small cell lung cancer (NSCLC).Int J Radiat Oncol Biol Phys,1999,45:323-329.
  • 4Kwa SL,Lebesque JV,Theuws JC,et al.Radiation pneumonitis as a function of mean lung dose:an analysis of pooled data of 540 patients.Int J Radiat Oncol Biol Phys,1998,42:1-9.
  • 5Kwa SL,Theuws JC,Wagenaar A,et al.Evaluation of two dosevolume histogram reduction models for the prediction of radiation pneumonitis.Radiother Oncol,1998,48:61-69.
  • 6Oetzel D,Schraube P,Hensley F,et al.Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.Int J Radiat Oncol Biol Phys,1995,33:455-460.
  • 7Hernando ML,Marks LB,Bentel GC,et al.Radiation-inducedpulmonary toxicity:a dose-volume histogram analysis in 201 patients with lung cancer.Int J Radiat Oncol Biol Phys,2001,51:650-659.
  • 8Marks LB.Dosimetric predictors of radiation-indueed lung injury.Int J Radiat Oncol Biol Phys,2002,54:313 -316.
  • 9Yorke ED,Jackson A,Rosenzweig KE,et al.Correlation of dosimetric factors and radiation pneumonitis for non-small cell lung cancer patients in a recently completed dose escalation study.Int J Radiat Oncol Biol Phys,2005,63:672-682.
  • 10Wang SL,Liao ZX,Wei X,et al.Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3DCRT).Int J Radiat Oncol Biol Phys,2006,66:1399-1407.

共引文献62

同被引文献45

  • 1Sonke J J,Belderbos J.Adaptive radiotherapy for lung cancer[J].Semin Radiat Oncol,2010,20(2):94-106.
  • 2Simone CB 2nd,Ly D,Dan TD,et al.Comparison of intensity-modulated radiotherapy,adaptive radiotherapy,proton radiotherapy,and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer[J].Radiother Oncol,2011,101 (3):376-382.
  • 3Worm ES,Hansen AT,Petersen JB,et al.Inter-and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and Lung[J].Acta Oncol,2010,49(7):1177-1183.
  • 4Cole AJ,O'Hare JM,McMahon SJ,et al.Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity,outcomes and dose escalation for radical lung cancer radiotherapy[J].Clin Oncol (R Coll Radiol),2014,26(3):142-150.
  • 5Giraud P,Antoine M,Larrouy A,et al.Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning[J].Int J Radiat Oncol Biol Phys,2000,48:1015-1024.
  • 6Osti MF,Agolli L,Valeriani M,et al.Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advancedstage non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2013,85(3):157-163.
  • 7Lavoie C,Higgins J,Bissonnette JP,et al.Volumetric image guidance using carina vs spine as registration landmarks for conventionally fractionated lung radiotherapy[J].Int J Radiat Oncol Biol Phys,2012,84(5):1086-1092.
  • 8Lim G,Bezjak A,Higgins J,et al.Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy[J].J Thorac Oncol,2011,6(3):531-536.
  • 9Tucker SL,Jin H,Wei X,et al.Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2010,77(3):691-698.
  • 10Zhang ZC,Xu J,Li BS,et al.Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung Cancer[J].Am J Clin Oncol,2010,33(3):271-275.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部